CIM
ZBH icon

Contravisory Investment Management’s Zimmer Biomet ZBH Stock Holding History

Contravisory Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16
Closed -$1.69K – 464
2024
Q4 		$1.69K Buy
+16
New +$1.72K ﹤0.01% 361
2023
Q4 		– Sell
-2,997
Closed -$336K – 430
2023
Q3 		$336K Buy
+2,997
New +$381K 0.1% 149

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Contravisory Investment Management's ZBH Position: Q1 2025 in Review

Contravisory Investment Management sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 16 shares — an estimated $1.69K sold.

Contravisory Investment Management first reported a position in ZBH in Q3 2023 and held it in 2 quarters. The position peaked at $336K in Q3 2023. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Contravisory Investment Management reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Contravisory Investment Management sold 16 Zimmer Biomet shares in Q1 2025, an estimated $1.69K.
  • Contravisory Investment Management first reported a position in Zimmer Biomet in Q3 2023 and held it in 2 quarters.
  • Contravisory Investment Management's Zimmer Biomet position peaked at $336K in Q3 2023.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Contravisory Investment Management's 13F filing for Q1 2025, filed 10 Apr 2025.